Sinopharm Group Co. Ltd. (SHTDY) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Sinopharm Group Co. Ltd.

OTC: SHTDY · Real-Time Price · USD
12.21
0.01 (0.04%)
At close: Sep 12, 2025, 3:50 PM
12.21
-0.04%
After-hours: Sep 12, 2025, 03:16 PM EDT

Sinopharm Income Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
584.51B 596.57B 552.15B 521.05B
Cost of Revenue
540.25B 548.06B 504.71B 477B
Gross Profit
44.26B 48.51B 47.43B 44.05B
Operating Income
16.19B 20.21B 20.6B 19.71B
Interest Income
n/a 526.21M 542.77M 558.56M
Pretax Income
14B 19.51B 18.56B 17B
Net Income
7.05B 9.05B 14.35B 13.06B
Selling & General & Admin
25.57B 26.15B 24.9B 23.2B
Research & Development
n/a n/a n/a n/a
Other Expenses
1.16B 2.15B -676.16M -589.19M
Operating Expenses
28.07B 28.3B 24.23B 22.61B
Interest Expense
n/a 2.96B 3.52B 3.76B
Selling & Marketing Expenses
17.16B 17.47B 16.72B 15.44B
Cost & Expenses
568.32B 576.36B 528.94B 499.61B
Income Tax Expense
3.58B 4.5B 4.22B 3.94B
Shares Outstanding (Basic)
624.11M 624.13M 624.13M 622.23M
Shares Outstanding (Diluted)
624.11M 624.13M 624.13M 622.23M
EPS (Basic)
11.30 14.50 23.00 21.00
EPS (Diluted)
11.30 14.50 23.00 21.00
EBITDA
20.17B 26.9B 26.25B 24.68B
EBIT
17.82B 22.47B 22.08B 20.76B
Depreciation & Amortization
2.36B 4.43B 4.17B 3.92B